Ambalal Sarabhai Enterprises P/B Ratio
Ambalal Sarabhai Enterprises (AMBALALSA) P/B ratio is 1.54 (Moderate), book value per share ₹20.52 vs Healthcare average P/B of -0.32 — Moderate - Reasonably valued relative to book value. Review AMBALALSA earnings multiple to evaluate earnings-based valuation against sector peers.
Current Valuation Metrics
Book Value Breakdown (2026)
Valuation Signal
Sector Context
AMBALALSA P/B Ratio — Valuation Insights & Book Value Analysis
Ambalal Sarabhai Enterprises price-to-book ratio interpretation, valuation status and historical context — current P/B 1.54 (Moderate). For live price, earnings yield and the full fundamental profile, see AMBALALSA stock price BSE.
- Current PB is 24.2% below historical average
- Trading at premium to sector average PB of -0.32
Ambalal Sarabhai Enterprises P/B Ratio Historical Trend
AMBALALSA annual price-to-book ratio — 5 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. View AMBALALSA annual price range for the annual high/low range and current price position.
AMBALALSA Historical P/B Ratio — Book Value Per Share & Year-End Price
Ambalal Sarabhai Enterprises annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2026 | 1.6 | ₹20.52 | ₹32.82 | ₹158 | Moderate |
| 2025 | 1.57 | ₹18.18 | ₹28.58 | ₹140 | Moderate |
| 2024 | 3.03 | ₹17.66 | ₹53.58 | ₹136 | High |
| 2023 | 2.23 | ₹17.01 | ₹38.02 | ₹131 | Moderate |
| 2022 | 1.73 | ₹15.58 | ₹26.90 | ₹120 | Moderate |
AMBALALSA vs Healthcare Peers — P/B Ratio Comparison
Ambalal Sarabhai Enterprises P/B 1.54 vs Healthcare average -0.32, median 0.6 — range -17.45–1.11.
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Rekvina Laboratories | VINRKLB | -17.45 | ₹21 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Parmax Pharma | PARMAX | -4.18 | ₹29 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -2.23 | ₹73 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.79 | ₹126 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |
| Vivimed Labs | VIVIMEDLAB | -0.56 | ₹50 | Low |